KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $325,000 | -15.8% | 20,196 | -26.7% | 0.02% | -26.1% |
| Q4 2021 | $386,000 | +46.2% | 27,537 | +117.4% | 0.02% | +64.3% |
| Q2 2021 | $264,000 | -46.0% | 12,666 | -26.8% | 0.01% | -50.0% |
| Q1 2021 | $489,000 | -42.1% | 17,305 | -33.0% | 0.03% | -54.1% |
| Q4 2020 | $844,000 | -56.2% | 25,827 | -58.9% | 0.06% | -3.2% |
| Q3 2020 | $1,927,000 | +94.1% | 62,901 | +3.3% | 0.06% | +142.3% |
| Q2 2020 | $993,000 | +111.7% | 60,899 | +29.1% | 0.03% | +116.7% |
| Q1 2020 | $469,000 | -37.6% | 47,155 | -13.8% | 0.01% | +9.1% |
| Q4 2019 | $752,000 | +234.2% | 54,724 | +303.0% | 0.01% | +120.0% |
| Q1 2019 | $225,000 | +16.0% | 13,579 | -2.0% | 0.01% | +25.0% |
| Q4 2018 | $194,000 | -40.3% | 13,851 | -25.5% | 0.00% | -42.9% |
| Q3 2018 | $325,000 | – | 18,592 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |